| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/11/2010 | US20100063045 Novel pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure |
| 03/11/2010 | US20100063044 Substituted aniline derivatives |
| 03/11/2010 | US20100063043 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics |
| 03/11/2010 | US20100063042 5-substituted benzoxazines |
| 03/11/2010 | US20100063041 Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same |
| 03/11/2010 | US20100063040 Sulfonamide Derivative Having PGD2 Receptor Antagonistic Activity |
| 03/11/2010 | US20100063038 Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis |
| 03/11/2010 | US20100063037 6-substituted benzoxazines |
| 03/11/2010 | US20100063036 Substituted morpholine and thiomorpholine derivatives |
| 03/11/2010 | US20100063035 Carbonic anhydrase inhibitors derivatives |
| 03/11/2010 | US20100063034 Conjugated psychotropic drugs and uses thereof |
| 03/11/2010 | US20100063033 administering (2,6-Dimethyl-4-morpholin-4-yl-phenyl)-carbamic acid butyl ester, for the treatment of bipolar disorders, seizure disorders, anxiety disorders, neuropathic pain and migraine pain disorders or neurodegenerative disorders |
| 03/11/2010 | US20100063032 Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators |
| 03/11/2010 | US20100063031 Kinase inhibitor compounds |
| 03/11/2010 | US20100063030 Benzenesulfonyl Compounds and the Use Thereof |
| 03/11/2010 | US20100063029 Use of s-10-hydroxy-10,11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders |
| 03/11/2010 | US20100063028 Triazabenzo[E]Azulene Derivatives for the Treatment Of Tumors |
| 03/11/2010 | US20100063027 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity |
| 03/11/2010 | US20100063026 Antibacterial quinoline derivatives |
| 03/11/2010 | US20100063025 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of RHO-Kinase |
| 03/11/2010 | US20100063024 Dihydropyrazolopyrimidinone Derivatives |
| 03/11/2010 | US20100063023 Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors |
| 03/11/2010 | US20100063022 Novel compounds as cannabinoid receptor ligands |
| 03/11/2010 | US20100063021 Modulators of muscarinic receptors |
| 03/11/2010 | US20100063020 Oral pharmaceutical formulations and methods for producing and using same |
| 03/11/2010 | US20100063019 Low Dose Estrogen Interrupted Hormone Replacement Therapy |
| 03/11/2010 | US20100063018 orphan nuclear receptor modulators such as 23-N-Carbacinnamyloxy-3 alpha ,7 alpha -dihydroxy-5 beta -norcholanylamine, used for the treatment of liver, gastrointestinal, kidney, cardiovascular or metabolic disorders |
| 03/11/2010 | US20100063017 Ophthalmic Suspension for Ocular Use |
| 03/11/2010 | US20100063016 Pharmaceutical Combinations |
| 03/11/2010 | US20100063015 Skin-care preparations containing mupirocin and betamethasone dipropionate |
| 03/11/2010 | US20100063014 Drug comprising at least one gestagen |
| 03/11/2010 | US20100063013 Cathepsin cysteine protease inhibitors |
| 03/11/2010 | US20100063012 Compositions and methods for the treatment of inflammatory diseases |
| 03/11/2010 | US20100063011 Organic compounds |
| 03/11/2010 | US20100063010 Method for administering a spill resistant pharmaceutical system |
| 03/11/2010 | US20100063009 Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1.3-diol and an NSAID |
| 03/11/2010 | US20100063008 Gelatinous elastomer compositions |
| 03/11/2010 | US20100063006 Compositions and methods to reduce fat and retract skin |
| 03/11/2010 | US20100063005 Methods for Treating Cystic Fibrosis or Pneumonia with Bacterial Infection via Pulmonary Administration of Fosfomycin |
| 03/11/2010 | US20100063004 Topical pharmaceutical composition |
| 03/11/2010 | US20100063003 Pet food composition |
| 03/11/2010 | US20100063002 Method of improving skills with a composition comprising non-digestible saccharide |
| 03/11/2010 | US20100063001 Microbial-derived chondroitin sulfate |
| 03/11/2010 | US20100063000 Food containing glycogen and use thereof |
| 03/11/2010 | US20100062999 Composition extracted from shark cartilage marrow |
| 03/11/2010 | US20100062998 Prevention and/or Treatment of Neurodegenerative Disorders |
| 03/11/2010 | US20100062997 lowering the incidence of thromboembolism after discontinuation of an initial treatment with an anticoagulant drug, by administering an initial treatment of idraparinux and then discontinuing such treatment |
| 03/11/2010 | US20100062996 Dioxolane derivates for the treatment of cancer |
| 03/11/2010 | US20100062995 Transition state structure of human 5'methylthioadenosine phosphorylase |
| 03/11/2010 | US20100062994 Adenosine Receptor Antagonists |
| 03/11/2010 | US20100062993 Adenosine Nucleotides as Dietary Supplements and as Agents in the Prevention of Cancer and the Metastasis Thereof |
| 03/11/2010 | US20100062992 Salts of 5-Azacytidine |
| 03/11/2010 | US20100062991 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof |
| 03/11/2010 | US20100062990 Novel pseudoglycolipid and use thereof |
| 03/11/2010 | US20100062989 OPTIMAL BIOLOGICAL MARKER FOR THE BIOLOGICAL POTENCY OF Emblica Officinalis Gaertn. (AMLA) FRUIT-METHODS AND PRODUCTS THEREOF |
| 03/11/2010 | US20100062988 Chewable sustained release formulations |
| 03/11/2010 | US20100062987 Anticonvulsive pharmaceutical compositions |
| 03/11/2010 | US20100062978 Method for inhibiting signal transduction, signal transduction inhibitor to be used therein and use thereof |
| 03/11/2010 | US20100062974 Combination therapy for the treatment of bacterial infections |
| 03/11/2010 | US20100062972 Triazole compounds and uses related thereto |
| 03/11/2010 | US20100062971 such as 2-{3-[2-(4-Methoxy-phenyl)-ethyl]-6-methyl-1H-indazol-4-yloxy} beta -D-glucopyranoside, used for for treating diabetes, Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, polycystic ovarian syndrome, hypertension, ischemia, stroke and cardiovascula disorders |
| 03/11/2010 | US20100062970 Synthesis of propyl phenoxy ethers and use as delivery agents |
| 03/11/2010 | US20100062969 Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders |
| 03/11/2010 | US20100062968 Novel strategies for delivery of active agents using micelles and particles |
| 03/11/2010 | US20100062967 Coated lipid complexes and their use |
| 03/11/2010 | US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 03/11/2010 | US20100062937 Benzanilides with insecticidal activity |
| 03/11/2010 | US20100062468 Methods and products related to low molecular weight heparin |
| 03/11/2010 | US20100062448 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases |
| 03/11/2010 | US20100062087 Nutraceutical Treatments for Diabetic and Non-Diabetic Wound Healing |
| 03/11/2010 | US20100062084 Treatment Of Gastrointestinal Diseases |
| 03/11/2010 | US20100062083 Dermal film-forming liquid formulations for drug release to skin |
| 03/11/2010 | US20100062081 Use of tellurium containing compounds as nerve protecting agents |
| 03/11/2010 | US20100062079 Polymorphisms predictive of platinum-coordinating complex induced ototoxicity |
| 03/11/2010 | US20100062078 Pharmaceutical composition for treating cancer and the signaling pathway thereof |
| 03/11/2010 | US20100062077 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
| 03/11/2010 | US20100062070 Pulverzed crystals of olmesartan medoxomil |
| 03/11/2010 | US20100062069 Process for preparing particles containing an antiviral |
| 03/11/2010 | US20100062066 Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration |
| 03/11/2010 | US20100062065 Pharmaceutical composition containing naphthoquinone-based compound for intestine delivery system |
| 03/11/2010 | US20100062064 Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof |
| 03/11/2010 | US20100062063 Light-stable solid pharmaceutical composition of ramosetron |
| 03/11/2010 | US20100062062 Stabilized Coating for Pharmaceutical Formulations |
| 03/11/2010 | US20100062061 Method For Making Cetirizine Tablets |
| 03/11/2010 | US20100062060 Pharmaceutical composition comprising tramadol and ketoprofen in association |
| 03/11/2010 | US20100062059 S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions |
| 03/11/2010 | US20100062056 Encapsulated picoplatin |
| 03/11/2010 | US20100062055 Lipid-based nitric oxide donors |
| 03/11/2010 | US20100062053 Cholestanol derivative for combined use |
| 03/11/2010 | US20100062051 Composition for treatment of cervix cancer |
| 03/11/2010 | US20100062050 Means and methods of enhancing delivery to biological systems |
| 03/11/2010 | US20100062049 Aqueous formulation for selective targeting and delivering gene to cancer cells |
| 03/11/2010 | US20100062048 Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds |
| 03/11/2010 | US20100062046 Polymorphs of nicotinic intermediates |
| 03/11/2010 | US20100062045 Method for suppressing coloring of adhesive prepartion containing donepezil and method for reducing amounts of donepezil-related substances formed |
| 03/11/2010 | US20100062040 Water soluble drugs and supplements |
| 03/11/2010 | US20100062039 Intravaginal Ringed Mesh Device And Applicator Therefor |
| 03/11/2010 | US20100062037 Subcutaneous implants releasing an active principle over an extended period of time |
| 03/11/2010 | US20100062023 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 03/11/2010 | US20100062007 Multi-modal cancer therapy using viral hitch-hiking |